191 related articles for article (PubMed ID: 27569001)
1. Predictive efficacy of the 2014 International Society of Urological Pathology Gleason grading system in initially diagnosed metastatic prostate cancer.
Sun GX; Shen PF; Zhang XM; Gong J; Gui HJ; Shu KP; Liu JD; Zhao J; Yang YJ; Chen XQ; Chen N; Zeng H
Asian J Androl; 2017; 19(5):573-578. PubMed ID: 27569001
[TBL] [Abstract][Full Text] [Related]
2. Predictive value of the 2014 International Society of Urological Pathology grading system for prostate cancer in patients undergoing radical prostatectomy with long-term follow-up.
Grogan J; Gupta R; Mahon KL; Stricker PD; Haynes AM; Delprado W; Turner J; Horvath LG; Kench JG
BJU Int; 2017 Nov; 120(5):651-658. PubMed ID: 28371244
[TBL] [Abstract][Full Text] [Related]
3. In Men with Castration-Resistant Prostate Cancer, Visceral Metastases Predict Shorter Overall Survival: What Predicts Visceral Metastases? Results from the SEARCH Database.
Whitney CA; Howard LE; Posadas EM; Amling CL; Aronson WJ; Cooperberg MR; Kane CJ; Terris MK; Freedland SJ
Eur Urol Focus; 2017 Oct; 3(4-5):480-486. PubMed ID: 28753787
[TBL] [Abstract][Full Text] [Related]
4. New Prostate Cancer Grading System Predicts Long-term Survival Following Surgery for Gleason Score 8-10 Prostate Cancer.
Ham WS; Chalfin HJ; Feng Z; Trock BJ; Epstein JI; Cheung C; Humphreys E; Partin AW; Han M
Eur Urol; 2017 Jun; 71(6):907-912. PubMed ID: 27876305
[TBL] [Abstract][Full Text] [Related]
5. The prognostic significance of Gleason scores in metastatic prostate cancer.
Rusthoven CG; Carlson JA; Waxweiler TV; Yeh N; Raben D; Flaig TW; Kavanagh BD
Urol Oncol; 2014 Jul; 32(5):707-13. PubMed ID: 24629494
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of Gleason score 3 + 4 = 7 prostate cancer with minimal amounts (<6%) vs ≥6% of Gleason pattern 4 tissue in needle biopsy specimens.
Kır G; Seneldir H; Gumus E
Ann Diagn Pathol; 2016 Feb; 20():48-51. PubMed ID: 26750655
[TBL] [Abstract][Full Text] [Related]
7. Validation of International Society of Urological Pathology (ISUP) grading for prostatic adenocarcinoma in thin core biopsies using TROG 03.04 'RADAR' trial clinical data.
Delahunt B; Egevad L; Srigley JR; Steigler A; Murray JD; Atkinson C; Matthews J; Duchesne G; Spry NA; Christie D; Joseph D; Attia J; Denham JW
Pathology; 2015 Oct; 47(6):520-5. PubMed ID: 26325671
[TBL] [Abstract][Full Text] [Related]
8. Prognostic Impacts of Metastatic Site and Pain on Progression to Castrate Resistance and Mortality in Patients with Metastatic Prostate Cancer.
Koo KC; Park SU; Kim KH; Rha KH; Hong SJ; Yang SC; Chung BH
Yonsei Med J; 2015 Sep; 56(5):1206-12. PubMed ID: 26256961
[TBL] [Abstract][Full Text] [Related]
9. Novel nomograms for castration-resistant prostate cancer and survival outcome in patients with de novo bone metastatic prostate cancer.
Zhao J; Sun G; Liao B; Zhang X; Armstrong CM; Yin X; Liu J; Chen J; Yang Y; Zhao P; Tang Q; Wang Z; Chen Z; Li X; Wei Q; Li X; Chen N; Gao AC; Shen P; Zeng H
BJU Int; 2018 Dec; 122(6):994-1002. PubMed ID: 29772102
[TBL] [Abstract][Full Text] [Related]
10. The expression profile and prognostic value of SPINK1 in initially diagnosed bone metastatic prostate cancer.
Pan X; Zhang X; Gong J; Tan J; Yin X; Tang Q; Shu K; Shen P; Zeng H; Chen N
Prostate; 2016 Jun; 76(9):823-33. PubMed ID: 27159572
[TBL] [Abstract][Full Text] [Related]
11. Improving the Rotterdam European Randomized Study of Screening for Prostate Cancer Risk Calculator for Initial Prostate Biopsy by Incorporating the 2014 International Society of Urological Pathology Gleason Grading and Cribriform growth.
Roobol MJ; Verbeek JFM; van der Kwast T; Kümmerlin IP; Kweldam CF; van Leenders GJLH
Eur Urol; 2017 Jul; 72(1):45-51. PubMed ID: 28162815
[TBL] [Abstract][Full Text] [Related]
12. Prostate-specific antigen level, stage or Gleason score: which is best for predicting outcomes after radical prostatectomy, and does it vary by the outcome being measured? Results from Shared Equal Access Regional Cancer Hospital database.
Mithal P; Howard LE; Aronson WJ; Kane CJ; Cooperberg MR; Terris MK; Amling CL; Freedland SJ
Int J Urol; 2015 Apr; 22(4):362-6. PubMed ID: 25728968
[TBL] [Abstract][Full Text] [Related]
13. Clinical Validation of the 2005 ISUP Gleason Grading System in a Cohort of Intermediate and High Risk Men Undergoing Radical Prostatectomy.
Faraj SF; Bezerra SM; Yousefi K; Fedor H; Glavaris S; Han M; Partin AW; Humphreys E; Tosoian J; Johnson MH; Davicioni E; Trock BJ; Schaeffer EM; Ross AE; Netto GJ
PLoS One; 2016; 11(1):e0146189. PubMed ID: 26731672
[TBL] [Abstract][Full Text] [Related]
14. From Gleason to International Society of Urological Pathology (ISUP) grading of prostate cancer.
Samaratunga H; Delahunt B; Yaxley J; Srigley JR; Egevad L
Scand J Urol; 2016 Oct; 50(5):325-9. PubMed ID: 27415753
[TBL] [Abstract][Full Text] [Related]
15. Differences in survival of prostate cancer Gleason 8-10 disease and the establishment of a new Gleason survival grading system.
Zhou Y; Lin C; Hu Z; Yang C; Zhang R; Ding Y; Wang Z; Tao S; Qin Y
Cancer Med; 2021 Jan; 10(1):87-97. PubMed ID: 33135335
[TBL] [Abstract][Full Text] [Related]
16. Outcomes and predictive factors of prostate cancer patients with extremely high prostate-specific antigen level.
Izumi K; Lin WJ; Miyamoto H; Huang CK; Maolake A; Kitagawa Y; Kadono Y; Konaka H; Mizokami A; Namiki M
J Cancer Res Clin Oncol; 2014 Aug; 140(8):1413-9. PubMed ID: 24747988
[TBL] [Abstract][Full Text] [Related]
17. The prognostic significance of the 2014 International Society of Urological Pathology (ISUP) grading system for prostate cancer.
Samaratunga H; Delahunt B; Gianduzzo T; Coughlin G; Duffy D; LeFevre I; Johannsen S; Egevad L; Yaxley J
Pathology; 2015 Oct; 47(6):515-9. PubMed ID: 26325670
[TBL] [Abstract][Full Text] [Related]
18. The Significance of Accurate Determination of Gleason Score for Therapeutic Options and Prognosis of Prostate Cancer.
Helpap B; Ringli D; Tonhauser J; Poser I; Breul J; Gevensleben H; Seifert HH
Pathol Oncol Res; 2016 Apr; 22(2):349-56. PubMed ID: 26563277
[TBL] [Abstract][Full Text] [Related]
19. Impact on the clinical outcome of prostate cancer by the 2005 international society of urological pathology modified Gleason grading system.
Dong F; Wang C; Farris AB; Wu S; Lee H; Olumi AF; McDougal WS; Young RH; Wu CL
Am J Surg Pathol; 2012 Jun; 36(6):838-43. PubMed ID: 22592143
[TBL] [Abstract][Full Text] [Related]
20. Application of a Prognostic Gleason Grade Grouping System to Assess Distant Prostate Cancer Outcomes.
Leapman MS; Cowan JE; Simko J; Roberge G; Stohr BA; Carroll PR; Cooperberg MR
Eur Urol; 2017 May; 71(5):750-759. PubMed ID: 27940155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
